Cefzlan AL Tablet containing Cefixime, Azithromycin, and Lactobacillus is used for the management of bacterial infections. It helps control infection-causing bacteria while supporting intestinal microbial balance during antibiotic therapy.
Cefixime works as a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Azithromycin prevents bacterial protein synthesis. Lactobacillus helps maintain healthy gut flora and supports digestive well-being.
The tablet is widely prescribed for respiratory tract infections, ENT infections, skin infections, and other susceptible bacterial conditions, leading to consistent prescription demand.
With increasing demand for broad-spectrum antibiotic therapies combined with probiotic support, this product offers strong business potential for retailers and distributors. Its triple-action formulation, established clinical relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.